Amova Asset Management Americas, Inc. / REGN
Amova Asset Management Americas, Inc.’s Regeneron Pharmaceuticals Position
Does Amova Asset Management Americas, Inc. own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 16.2K shares worth $12M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$12M
Q4 2025
Shares
16.2K
% of Portfolio
+0.14%
Quarters Held
28
position exited
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 16.2K | $12M | +0.14% |
| Q3 2025 | 20.2K | $11M | +0.11% |
| Q2 2025 | 23.3K | $12M | +0.12% |
| Q1 2025 | 24.2K | $15M | +0.20% |
| Q4 2024 | 26.2K | $19M | +0.20% |
| Q3 2024 | 28.9K | $30M | +0.34% |
| Q2 2024 | 31.0K | $33M | +0.38% |
| Q1 2024 | 33.3K | $32M | +0.32% |
| Q4 2023 | 35.0K | $31M | +0.30% |
| Q3 2023 | 36.8K | $30M | +0.36% |
| Q2 2023 | 38.3K | $28M | +0.29% |
| Q1 2023 | 38.3K | $31M | +0.35% |
| Q4 2022 | 41.5K | $30M | +0.43% |
| Q3 2022 | 42.5K | $29M | +0.38% |
| Q2 2022 | 54.6K | $30M | +0.37% |
| Q1 2022 | 69.2K | $47M | +0.35% |
| Q4 2021 | 91.3K | $58M | +0.31% |
| Q3 2021 | 121.9K | $70M | +0.30% |
| Q2 2021 | 157.5K | $87M | +0.34% |
| Q1 2021 | 79.6K | $38M | +0.18% |
| Q4 2020 | 53.9K | $26M | +0.15% |
| Q3 2020 | 28.4K | $16M | +0.14% |
| Q2 2020 | 35.0K | $21M | +0.28% |
| Q1 2020 | 123.3K | $60M | +0.56% |
| Q4 2019 | 145.2K | $55M | +0.86% |
| Q3 2019 | 159.6K | $44M | +0.79% |
| Q2 2019 | 123.7K | $39M | +0.76% |
| Q1 2019 | 23.0K | $9M | +0.25% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amova Asset Management Americas, Inc.’s full portfolio or all institutional holders of REGN.